Focal segmental glomerulosclerosis primary prevention: Difference between revisions
(Created page with "__NOTOC__ {{Focal segmental glomerulosclerosis}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing...") |
|||
(One intermediate revision by the same user not shown) | |||
Line 2: | Line 2: | ||
{{Focal segmental glomerulosclerosis}} | {{Focal segmental glomerulosclerosis}} | ||
{{CMG}} {{AE}} {{MKK}} | |||
==Overview== | |||
==Primary prevention== | |||
There are no established measures for the primary prevention of [disease name]. | |||
OR | |||
There are no available vaccines against [disease name]. | |||
OR | |||
Effective measures for the primary prevention of [disease name] include: | |||
*[Measure1] | |||
*[Measure2] | |||
*[Measure3] | |||
OR | |||
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include: | |||
*[Strategy 1] | |||
*[Strategy 2] | |||
*[Strategy 3] | |||
==References== | ==References== |
Latest revision as of 15:27, 21 June 2018
Focal segmental glomerulosclerosis Microchapters |
Differentiating Focal segmental glomerulosclerosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Focal segmental glomerulosclerosis primary prevention On the Web |
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis primary prevention |
FDA on Focal segmental glomerulosclerosis primary prevention |
CDC on Focal segmental glomerulosclerosis primary prevention |
Focal segmental glomerulosclerosis primary prevention in the news |
Blogs on Focal segmental glomerulosclerosis primary prevention |
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
Risk calculators and risk factors for Focal segmental glomerulosclerosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Primary prevention
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3]
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]